Clinical trial
An Exploratory Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
NCT03189641 is registered in ClinicalTrials.gov with JIMRO Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
- Lead sponsor
- JIMRO Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2017
- Completion date
- July 26, 2024
- Enrollment
- 30 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.